Group 1 - The company plans to globally offer 67.91 million shares, with 6.79 million shares for Hong Kong and 61.12 million shares for international sale [1] - The subscription period is from May 19 to May 22, with a maximum offer price of HKD 10.68 per share and an entry fee of approximately HKD 5,393.85 for 500 shares [1] - The total expected fundraising amount is HKD 617 million, with a net amount of HKD 505 million, which will be used for technology development, enhancing data analysis capabilities, and expanding revenue sources [1] Group 2 - The company has introduced cornerstone investors including Shen Zhenyu, Yulong International Capital Limited, and Timber Kangaroo Capital Limited, who will subscribe to approximately 14.55 million shares at the offer price [1] - The company is expected to be listed on the main board on May 27, 2025, with China International Capital Hong Kong Securities Limited and CMB International Capital Limited as joint sponsors [1] Group 3 - The company's main business includes professional design services, software development, IT consulting, and sales of various medical devices and consumer products [2] - The company reported net profits of CNY 345 million, CNY 182 million, and CNY 59.16 million for the fiscal years 2023, 2024, and the first quarter of 2025, with year-on-year changes of 87.57%, -47.28%, and 38.21% respectively [3]
吉宏股份 5月19日起招股